EUVIMEDEUVIMED entdecken
Crossref

Recent advances in the use of lipid nanoparticles (LNPs) as delivery vectors for mRNA

jianmei Li, wenlin Wu, jie Dai, xingchen Peng

Nano Research · 26.10.2026

DOI: 10.26599/nr.2026.94909290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Research, online erschienen am 26.10.2026. Verfasst von jianmei Li und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic mRNA has demonstrated great promise in infectious disease vaccines, cancer immunotherapy, and protein replacement therapies. However, its clinical translation is hampered by intrinsic limitations, including rapid degradation, poor membrane permeability, extremely low endosomal escape, lack of tissue specificity, and potential immunogenicity. Naked mRNA alone is insufficient to overcome these challenges, which has driven the emergence of lipid nanoparticles (LNPs) as the leading clinical-grade delivery platform. LNPs employ a four-component system: ionizable lipids for encapsulation and pH-responsive fusion; helper phospholipids and cholesterol for structural integrity and membrane fluidity; and PEGylated lipids for colloidal stability and prolonged circulation. This review systematically addresses LNP composition, structure–activity relationships, and the interplay with extrinsic factors—including administration routes, targeting ligands, immunostimulant co-delivery, and organ tropism (liver, spleen, lungs, lymph nodes)—that collectively govern mRNA biodistribution and therapeutic efficacy. Nonetheless, several major bottlenecks persist, such as unclear endosomal escape mechanisms, PEG-related immune interference, obstacles to extrahepatic delivery, manufacturing complexities, and challenges in AI-driven lipid design. Future progress will rely on integrating rational design, high-throughput screening, and engineering innovations to develop precision delivery systems that are safe, efficient, and amenable to repeated administration—thereby fully unlocking the clinical potential of mRNA-based therapies.

Zitieren

APA

Li, J., Wu, W., Dai, J., & Peng, X. (2026). Recent advances in the use of lipid nanoparticles (LNPs) as delivery vectors for mRNA. Nano Research. https://doi.org/10.26599/nr.2026.94909290

Vancouver

Li J, Wu W, Dai J, Peng X. Recent advances in the use of lipid nanoparticles (LNPs) as delivery vectors for mRNA. Nano Research. 2026. doi:10.26599/nr.2026.94909290

BibTeX
@article{Li2026,
  author = {Li, jianmei and Wu, wenlin and Dai, jie and Peng, xingchen},
  title = {Recent advances in the use of lipid nanoparticles (LNPs) as delivery vectors for mRNA},
  journal = {Nano Research},
  year = {2026},
  doi = {10.26599/nr.2026.94909290}
}
Kostenlos starten →